Target Group Inc. (CBDY)
OTCMKTS · Delayed Price · Currency is USD
0.0017
+0.0002 (13.33%)
Aug 8, 2025, 9:36 AM EDT
ATSG Revenue
Target Group had revenue of $1.40M in the quarter ending March 31, 2025, a decrease of -27.06%. This brings the company's revenue in the last twelve months to $6.07M, up 7.66% year-over-year. In the year 2024, Target Group had annual revenue of $6.59M with 77.19% growth.
Revenue (ttm)
6.07M
Revenue Growth
+7.66%
P/S Ratio
0.17
Revenue / Employee
144.57K
Employees
41
Market Cap
1.05M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.59M | 2.87M | 77.19% |
Dec 31, 2023 | 3.72M | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | 30.00K | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Global Cord Blood | 196.10M |